GW & Wade’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $18.7M | Buy |
236,351
+6,790
| +3% | +$483K | 0.61% | 48 |
|
|
2023
Q3 | $16M | Buy |
229,561
+4,832
| +2% | +$342K | 0.6% | 51 |
|
|
2023
Q2 | $15.5M | Buy |
224,729
+16,237
| +8% | +$1.16M | 0.56% | 57 |
|
|
2023
Q1 | $15.5M | Buy |
208,492
+7,788
| +4% | +$653K | 0.6% | 56 |
|
|
2022
Q4 | $18.7M | Buy |
200,704
+2,577
| +1% | +$249K | 0.77% | 41 |
|
|
2022
Q3 | $18.9M | Sell |
198,127
-38,490
| -16% | -$3.81M | 0.93% | 29 |
|
|
2022
Q2 | $21.9M | Buy |
236,617
+38,595
| +19% | +$3.77M | 0.99% | 24 |
|
|
2022
Q1 | $20M | Buy |
198,022
+4,564
| +2% | +$479K | 0.86% | 31 |
|
|
2021
Q4 | $20M | Buy |
193,458
+3,760
| +2% | +$347K | 0.87% | 33 |
|
|
2021
Q3 | $16.1M | Buy |
189,698
+4,040
| +2% | +$338K | 0.76% | 44 |
|
|
2021
Q2 | $15.5M | Buy |
185,658
+2,702
| +1% | +$221K | 0.74% | 45 |
|
|
2021
Q1 | $13.8M | Buy |
182,956
+19,440
| +12% | +$1.42M | 0.73% | 47 |
|
|
2020
Q4 | $11.2M | Buy |
163,516
+6,378
| +4% | +$415K | 0.68% | 52 |
|
|
2020
Q3 | $9.18M | Buy |
157,138
+12,623
| +9% | +$785K | 0.7% | 51 |
|
|
2020
Q2 | $9.39M | Sell |
144,515
-1,696
| -1% | -$107K | 0.77% | 43 |
|
|
2020
Q1 | $8.68M | Buy |
146,211
+8,720
| +6% | +$582K | 0.82% | 44 |
|
|
2019
Q4 | $10.2M | Buy |
137,491
+3,192
| +2% | +$224K | 0.78% | 46 |
|
|
2019
Q3 | $8.47M | Sell |
134,299
-8,530
| -6% | -$505K | 0.72% | 50 |
|
|
2019
Q2 | $7.78M | Sell |
142,829
-3,417
| -2% | -$184K | 0.71% | 48 |
|
|
2019
Q1 | $7.89M | Sell |
146,246
-20,791
| -12% | -$1.28M | 0.75% | 44 |
|
|
2018
Q4 | $10.9M | Buy |
167,037
+15,131
| +10% | +$1.13M | 1.18% | 26 |
|
|
2018
Q3 | $12M | Buy |
151,906
+2,416
| +2% | +$173K | 1.27% | 25 |
|
|
2018
Q2 | $9.62M | Sell |
149,490
-29,628
| -17% | -$1.95M | 1.08% | 36 |
|
|
2018
Q1 | $11.1M | Buy |
179,118
+170,144
| +1,896% | +$12.2M | 1.29% | 23 |
|
|
2017
Q4 | $651K | Sell |
8,974
-867
| -9% | -$63K | 0.07% | 125 |
|
|
2017
Q3 | $800K | Sell |
9,841
-431
| -4% | -$34.1K | 0.1% | 108 |
|
|
2017
Q2 | $826K | Sell |
10,272
-151
| -1% | -$11.9K | 0.1% | 106 |
|
|
2017
Q1 | $818K | Buy |
10,423
+789
| +8% | +$63K | 0.11% | 103 |
|
|
2016
Q4 | $760K | Sell |
9,634
-9,281
| -49% | -$751K | 0.13% | 100 |
|
|
2016
Q3 | $1.68M | Sell |
18,915
-21,035
| -53% | -$1.99M | 0.3% | 68 |
|
|
2016
Q2 | $3.83M | Buy |
39,950
+20,830
| +109% | +$2.08M | 0.66% | 43 |
|
|
2016
Q1 | $1.98M | Sell |
19,120
-255
| -1% | -$24.8K | 0.39% | 57 |
|
|
2015
Q4 | $1.89M | Sell |
19,375
-609
| -3% | -$59.6K | 0.4% | 58 |
|
|
2015
Q3 | $1.93M | Buy |
19,984
+1,093
| +6% | +$115K | 0.43% | 60 |
|
|
2015
Q2 | $1.98M | Sell |
18,891
-665
| -3% | -$67.9K | 0.39% | 60 |
|
|
2015
Q1 | $2.02M | Buy |
19,556
+8,799
| +82% | +$890K | 0.38% | 61 |
|
|
2014
Q4 | $1.04M | Hold |
10,757
| – | – | 0.27% | 66 |
|
|
2014
Q3 | $856K | Sell |
10,757
-255
| -2% | -$20.1K | 0.25% | 65 |
|
|
2014
Q2 | $830K | Hold |
11,012
| – | – | 0.24% | 65 |
|
|
2014
Q1 | $824K | Hold |
11,012
| – | – | 0.27% | 64 |
|
|
2013
Q4 | $788K | Hold |
11,012
| – | – | 0.26% | 65 |
|
|
2013
Q3 | $625K | Sell |
11,012
-250
| -2% | -$14.9K | 0.22% | 69 |
|
|
2013
Q2 | $644K | Buy |
+11,262
| New | +$652K | 0.23% | 68 |
|
Other funds holding CVS
GW & Wade's CVS Position: Q4 2023 in Review
GW & Wade increased its CVS Health (CVS) stake by 3% in Q4 2023, buying an estimated $483K and bringing the position to 236,351 shares worth $18.7M. The position accounts for 0.61% of the portfolio, ranked #48.
GW & Wade first reported a position in CVS in Q2 2013 and has held it in 43 quarters since. The position peaked at $21.9M in Q2 2022. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.
- GW & Wade held 236,351 shares of CVS Health worth $18.7M as of Q4 2023.
- GW & Wade bought 6,790 CVS Health shares in Q4 2023, an estimated $483K.
- CVS Health made up 0.61% of GW & Wade's portfolio in Q4 2023, its #48 holding.
- GW & Wade first reported a position in CVS Health in Q2 2013 and has held it in 43 quarters since.
- GW & Wade's CVS Health position peaked at $21.9M in Q2 2022.
- 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.